Suppr超能文献

重度乙型血友病患者单次使用重组凝血因子 IX(BeneFIX)联合局部措施拔牙的处理方法。

Management of third molar removal with a single dose of recombinant Factor IX (BeneFIX) and local measures in severe haemophilia B.

机构信息

The Alfred Hospital, Prahran, Victoria.

出版信息

Aust Dent J. 2010 Sep;55(3):322-4. doi: 10.1111/j.1834-7819.2010.01242.x.

Abstract

BACKGROUND

Patients with inherited bleeding disorders have historically had factor cover for oral surgery. Factor support is expensive, time consuming and places the patient at a potential risk of blood-borne diseases. This case describes the use of a significant reduction in factor support for a severe haemophilia B patient having third molars surgically removed.

METHODS

Local measures were used after a single preoperative dose of Factor IX to obtain good postoperative haemostasis.

RESULTS

Excellent haemostasis was achieved using local measures of 5% tranexamic acid solution, Surgicel® and Monocryl® sutures after a single preoperative dose of Factor IX.

CONCLUSIONS

Oral surgery may be performed on patients with inherited bleeding disorders using minimal factors and local haemostatic measures. A study of this patient population has commenced at The Alfred Hospital.

摘要

背景

患有遗传性出血性疾病的患者在接受口腔手术时通常需要使用凝血因子进行预防。凝血因子治疗既昂贵又耗时,并且使患者面临潜在的血液传播疾病风险。本病例描述了一名重度乙型血友病患者在接受第三磨牙手术时,通过显著减少凝血因子用量来获得良好的术后止血效果。

方法

在单次术前使用凝血因子 IX 后,采用局部措施获得良好的术后止血效果。

结果

单次术前使用凝血因子 IX 后,使用 5%氨甲环酸溶液、Surgicel®和 Monocryl®缝线等局部止血措施可获得良好的止血效果。

结论

对于患有遗传性出血性疾病的患者,采用最少的凝血因子和局部止血措施即可进行口腔手术。目前,我们已在阿尔弗雷德医院开始对这一患者群体进行研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验